Open Access Open Access  Restricted Access Subscription Access

Managing Oral and Salivary Gland Disorders: Insights into Pharmacotherapy

Gnana Lahari R, Muralinath E., Pooja Devi, Prasanta Chbukdhara, Sanjib Borah, Kalyan C., Archana Jain, Guruprasad M.

Abstract


Oral and salivary gland disorders cover a wide range of conditions impacting  the mouth, teeth, and salivary glands, ranging from common issues  namely  dental caries to more complex diseases such as Sjögren's syndrome and salivary gland tumors. While preventive dental care remains fundamental in maintaining oral health, pharmacotherapy plays an important  role in managing symptoms, regulating  inflammation and enhancing  quality of life for individuals with these disorders. In this article, we  provide an information regarding various drugs used in the treatment of oral and salivary gland disorders in humans.

                                                 The mouth contains salivary glands. Three sets of sizable salivary glands are present. Each ear's front and somewhat below are home to paratid glands. The jaw is below the submandibular glands. The tongue is covered in sublingual glands. Numerous smaller glands number in the hundreds. Through apertures known as ducts, these glands produce saliva, or spit, which is then released into the mouth. Food becomes moistened by saliva, aiding in swallowing, chewing, and food digestion. Because saliva includes antibodies that destroy pathogens, it also keeps the mouth healthy and clean.

Damage to the salivary glands or insufficient saliva production can alter taste, complicate chewing and swallowing, and raise the risk of oral infections, cavities, and tooth loss.


Full Text:

PDF

References


Ogle OE: Salivary gland diseases. Dent Clin North Am. 2020, 64:87-104. 10.1016/j.cden.2019.08.007

Jones RH, Findlay GJ: The management of benign salivary disease: a case series. Aust Dent J. 2013, 58:112-6. 10.1111/adj.12026

Colonia-García A, Bonadio-de-Carvalho H, Sgaviolli-Massucato EM, Soares-Marques YM, De-Andrade CR: [Salivary glands: a clinical-histopathological study]. CES Odontol. 2019, 32:15-23. 10.21615/cesodon.32.1.2

Ansari MH: Salivary gland tumors in an Iranian population: a retrospective study of 130 cases. J Oral Maxillofac Surg. 2007, 65:2187-94. 10.1016/j.joms.2006.11.025

Young A, Okuyemi OT: Malignant Salivary Gland Tumors. StatPearls Publishing, Treasure Island, FL; 2021.

Buchner A, Merrell PW, Carpenter WM: Relative frequency of intra-oral minor salivary gland tumors: a study of 380 cases from northern California and comparison to reports from other parts of the world. J Oral Pathol Med. 2007, 36:207-14. 10.1111/j.1600-0714.2007.00522.x

Wolff A, Joshi RK, Ekström J, et al.: A guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: a systematic review sponsored by the World Workshop on Oral Medicine VI. Drugs R D. 2017, 17:1-28. 10.1007/s40268-016-0153-9

Omhare A, Singh SK, Nigam JS, Sharma A: Cytohistopathological study of salivary gland lesions in Bundelkhand region, Uttar Pradesh, India. Patholog Res Int. 2014, 2014:804265. 10.1155/2014/804265

Delli K, Spijkervet FK, Vissink A: Salivary gland diseases: infections, sialolithiasis and mucoceles. Monogr Oral Sci. 2014, 24:135-48. 10.1159/000358794

Gellrich D, Bichler M, Reichel CA, Schrötzlmair F, Zengel P: Salivary gland disorders in children and adolescents: a 15-year experience. Int Arch Otorhinolaryngol. 2020, 24:e31-7. 10.1055/s-0039-1697993

Lo Giudice G, Marra PM, Colella C, Itro A, Tartaro G, Colella G: Salivary gland disorders in pediatric patients: a 20 years’ experience. Appl Sci. 2022, 12:1999. 10.3390/app12041999

Żurek M, Rzepakowska A, Jasak K, Niemczyk K: The epidemiology of salivary glands pathologies in adult population over 10 years in Poland-cohort study. Int J Environ Res Public Health. 2021, 19:179. 10.3390/ijerph19010179

Kondratowicz GM, Smallman LA, Morgan DW: Clinicopathological study of myoepithelial sialadenitis and chronic sialadenitis (sialolithiasis). J Clin Pathol. 1988, 41:403-9. 10.1136/jcp.41.4.403

Ashraf A, Shaikh AS, Kamal F, Sarfraz R, Bukhari MH: Diagnostic reliability of FNAC for salivary gland swellings: a comparative study. Diagn Cytopathol. 2010, 38:499-504. 10.1002/dc.21211

Thotambailu AM, Bhandary BS: A study of clinicopathological profile of salivary gland swellings. Indian J Otolaryngol Head Neck Surg. 2019, 71:253-7. 10.1007/s12070-018-1258-y

Achalkar GV: A clinicopathological study of salivary gland tumors. J Evol Med Dent Sci. 2013, 2:9726-32.

Mimura M, Tanaka N, Ichinose S, Kimijima Y, Amagasa T: Possible etiology of calculi formation in salivary glands: biophysical analysis of calculus. Med Mol Morphol. 2005, 38:189-95. 10.1007/s00795-005-0290-7

Marchal F, Dulguerov P: Sialolithiasis management: the state of the art. Arch Otolaryngol Head Neck Surg. 2003, 129:951-6. 10.1001/archotol.129.9.951

Kopeć T, Wierzbicka M, Kałużny J, Młodkowska A, Szyfter W: Sialendoscopy and sialendoscopically-assisted operations in the treatment of lithiasis of the submandibular and parotid glands: our experience of 239 cases. Br J Oral Maxillofac Surg. 2016, 54:767-71. 10.1016/j.bjoms.2016.04.026

Nadig SD, Ashwathappa DT, Manjunath M, Krishna S, Annaji AG, Shivaprakash PK: A relationship between salivary flow rates and Candida counts in patients with xerostomia. J Oral Maxillofac Pathol. 2017, 21:316. 10.4103/jomfp.JOMFP_231_16

Pires FR, Pringle GA, de Almeida OP, Chen SY: Intra-oral minor salivary gland tumors: a clinicopathological study of 546 cases. Oral Oncol. 2007, 43:463-70. 10.1016/j.oraloncology.2006.04.008

Wang D, Li Y, He H, Liu L, Wu L, He Z: Intraoral minor salivary gland tumors in a Chinese population: a retrospective study on 737 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007, 104:94-100. 10.1016/j.tripleo.2006.07.012

Ito FA, Ito K, Vargas PA, de Almeida OP, Lopes MA: Salivary gland tumors in a Brazilian population: a retrospective study of 496 cases. Int J Oral Maxillofac Surg. 2005, 34:533-6. 10.1016/j.ijom.2005.02.005

Niklander S, Veas L, Barrera C, Fuentes F, Chiappini G, Marshall M: Risk factors, hyposalivation and impact of xerostomia on oral health-related quality of life. Braz Oral Res. 2017, 31:e14. 10.1590/1807-3107BOR-2017.vol31.0014

Millsop JW, Wang EA, Fazel N: Etiology, evaluation, and management of xerostomia. Clin Dermatol. 2017, 35:468-76. 10.1016/j.clindermatol.2017.06.010

Lawal AO, Adisa AO, Kolude B, Adeyemi BF, Olajide MA: A review of 413 salivary gland tumours in the head and neck region. J Clin Exp Dent. 2013, 5:e218-22. 10.4317/jced.51143

Araya J, Martinez R, Niklander S, Marshall M, Esguep A: Incidence and prevalence of salivary gland tumours in Valparaiso, Chile. Med Oral Patol Oral Cir Bucal. 2015, 20:e532-9. 10.4317/medoral.20337

Arany, S., Kopycka-Kedzierawski, D. T., Caprio, T. V., & Watson, G. E. (2021). Anticholinergic medication: Related dry mouth and effects on the salivary glands. Oral surgery, oral medicine, oral pathology and oral radiology, 132(6), 662-670.

Reksten, T. R., & Jonsson, M. V. (2014). Sjögren's syndrome: an update on epidemiology and current insights on pathophysiology. Oral and Maxillofacial Surgery Clinics, 26(1), 1-12.

Kumari, P., Debta, P., & Dixit, A. (2022). Oral potentially malignant disorders: etiology, pathogenesis, and transformation into oral cancer. Frontiers in pharmacology, 13, 825266.


Refbacks

  • There are currently no refbacks.